Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the safety and efficacy of novel autologous
CAR-T cells in patients with hematopoietic and lymphoid malignancies.